Get started

AIM

Datatec showing strong upside after breakout of C&H to R49.21Cup and Handle has formed on Datatec after a couple of months. Since the price drop, it's been creeping up closing the gap ever so discreetly. We can even say it's created some type of upward channel. Either way it's looking bullish and other indicators confirm... 7>21>200 RSI>50 Target R49.21 ABOUT THE COMPANY Datatec Limited is an international ICT solutions and services group operating in more than 50 countries across North America, Latin America, Europe, Africa, Middle East, and Asia-Pacific "Datatec" is likely a compound of two words: "data" and "technology" (shortened to "tec") Founding: Datatec was founded in 1986 by Jens Montanana in Johannesburg, South Africa. Public Listing: The company was listed on the Johannesburg Stock Exchange (JSE) in 1994. It's also listed on the Alternative Investment Market (AIM) of the London Stock Exchange. Global Reach: Datatec operates globally through three main divisions: Westcon International, Logicalis, and Analysys Mason. Westcon International: This division is a technology distributor, specializing in security, collaboration, networking, and data center solutions. Logicalis: Logicalis is an international IT solutions and managed services provider with a breadth of knowledge and expertise in communications and collaboration; data center and cloud services; and managed services. Analysys Mason: This division provides specialist consulting and research services to telecoms, media, and technology industries worldwide.
JSE:DTCLong
by Timonrosso
Breakout for a 2,200%-plus return?This is Carclo, an industrial share listed on the London Stock Exchange’s Alternative Investment Market. It looks like it is breaking out from a 68-month decline that, if the past is any guide, could return huge multiples on any investment at this stage. Some of this company’s subsidiaries have been trading almost 100 years, but this century it has been a hugely volatile share. It began with the general market decline after the dotcom bubble at the turn of the millennium. A major slide in price was triggered in June 2000, bringing it down almost 90% from peak to trough across 33 months. It took 26 months for the share to rebound to the 50% Fib (this share loves a Fibonacci level) and, after hitting resistance there, retraced to the .382 Fib where it bobbled along for the best part of a year. By August 2007 it had risen 650% from the bottom. But then came a double top and another major decline, hitting resistance at the 50% Fib in September 2008 and setting eight months’ worth of relative equal highs from there. (A very nice trading range, that.) Price reversed again at the .236 Fib and this was where the fun started. Across the next four years, Carclo rose 1,000%, trough to peak. Since that January 2013 peak, another double top almost 10 years ago to the day, Carclo has been in seemingly terminal decline. There can’t be many bulls left to sell and you get the sense capitulation is around the corner. Although there was a slight recovery in price from November 2014 to June 2017 (31 months), it met resistance at the .236 Fib and rolled over again. The peak-to-trough decline, at the nadir of the Covid lockdowns in 2020, was 99.19%. But this is no junk share. It has had its problems with its pension liabilities and with debt but it has arranged new banking facilities with its lenders that give it good headroom. Net assets are almost £30m against a market cap of <£10m. But the key thing is how *every single time* this share has opened on the monthly above the trendline after a multi-month decline, it has sparked a tremendous rally in price over the medium term. It opened above again yesterday. I’m eyeing as my first TP the 50% Fib on the most recent decline, where there are five months of relative equal highs to mitigate. From there, a return to the .618 Fib on the broader, 67-month downtrend would also draw price to the monthly swing low and ICT fair-value gap from June 2013, which also remains unmitigated. And if you believe in cups and handles and head-and-shoulders patterns, there’s every reason to believe a C&H and inverse H&S could form very soon. Hitting the .618 Fib at 317p would constitute a near 2,200% return for anyone investing today. Better still, given the current zeitgeist of war and ageing populations, Carclo’s specialisms (e.g. heavy-duty cabling for the aviation industry and technical plastics for the medical sector) could create a new era of enormous value for the business. Who’s to say it wouldn’t rocket beyond old support-and-resistance levels to make new ATHs? After all, this share has made big, big moves before. BUT DYOR. GLA.
LSE:CARLong
by Bottle_Rocket
Train about to leave - Last CallSomething tells me this is your last chance to get on the AVACTA train. Fundamentals - We are awaiting the results of phase 1 trials, and all things are pointing for it to be very positive. - A great pipeline of drug development - Possible Take-over bids incoming - With a little research, the list goes on and on to be honest for Avacta. Charts - Higher time frame, we have formed this bull flag from the previous impulse move. - Price action has consolidated and we now have decent accumulation/consolidation under the upper resistance of the flag pattern. - On to this, price action and lagging span is about to be trading above the ichimoku cloud on pretty much all important time frames. 15 minute through to 1 day. When you get this confluence across time frames it can be very exciting. Price predictions for me are. - 140p within 2 weeks - 200p+ end of September.
LSE:AVCTLong
by t_trad_coach
2
AIM 1W Final Edit Wave (4) (A)(B)(C) CorrectiveTest AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.
AMEX:AIMLong
by TheCryptoChartWhisperer
Saham AIM Market kelihatan menarik tetapi ada halangan besar yang boleh terjadi bila bila masa. berikutan adanya kewujudan GAP yang amat besar.trend masih lagi uptrend, price bermain sekitar 0.255, dari segi analisis harga mampu bergerak sehingga 0.350. dari segi major trend pula, kemungkinan harga akan melakukan retracement sekiranya ada berita yang memberi kesan buruk pada saham AIM. dari gambaran ini, sedikit risiko diambil , dengan menjangkakan harga mampu menembusi hingga 0.380, trend kukuh menaik, tiada isu isu panas market , dalam bila bila masa sahaja market akan meroket apabila suntikan dana dari dana yang besar boleh menyebabkan harga bergerak keatas.
ALong
by tradelive2012
Keras Resources #KRS - Ranges here then moon 2015-6 style?Let's run through some indicators to flesh out a potential fractal whereby the share price enters a trading range around the current level before going on a moon mission (most likely triggered by Togo news and ongoing newsflow from Utah): 1. RSI - Sub-30 in March and settling at 40. Prior to this, the RSI has always bounced off 30. However, the last time it went sub-30 was at the start of 2015 and spent the rest of the year between 40-50 before going on a moon mission in 1H 2016. Therefore, the current level may well be the floor if this continues to range. 2. Volume Profile - For 2015, the POC was 0.6p and the share price hung around here for the first half. This means buyers and sellers were in agreement before it fell below in H2. If we look at the profile for YTD 2020, POC and share price are in lockstep. This time, however, I'd expect the share price to move up with 0.12p acting as the floor for this trading range (this is the recent placing price and I'd expect placees to bail out between 0.12p-0.13p as they'll use the warrants to benefit from any future upside. 3. Symmetrical Triangle - As you might see on my recent ideas, symmetrical triangles are everywhere I look. Given the uptrend since March, I'd say this looks like bullish continuation (e.g. taking a breather before moving up again). I'd say we have 3 weeks for the share price to decide which way it breaks the triangle. Whilst I think it breaks up, it probably won't be anything dramatic and will just mark the top of a trading range and move sideways until major newsflow arrives (i.e. Togo). Thoughts: Based on (i) how 2015 panned out as a ranging period (e.g. sideways movement), share price currently at POC (buyers and sellers are in agreement so ultimately the price needs to move above or below) and the symmetrical triangle, I believe there will be a modest upside breakout in the next few weeks but this will just be a new trading range before a moon mission if positive news comes out of Togo allowing production to go ahead etc etc.
KLong
by AttilaTheKiller
AIM can hit $3.85 ~ Actual TargetFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said at a buy entry now, than sell good till canceled order at $3.85, I think something like this can actually be reached quite soon. AIM started having some strong support, and you can start seeing accumulation growth, and likely at some point small cap funds will start getting interested in holding it. I am obviously bullish in this one.
AMEX:AIMLong
by gamer456148
Bombed out Natural Gas Play1. Compare the chart to the Wall Street Cheat Sheet and looks like we're in the Depression phase. Quiet on Twitter and bitter sentiment on LSE/ADVFN, nice contrarian signals and not a crowded trade. 2. POC at 1.4p. Sharp capitulation from January to Mid-March where RSI hit 18 and has recovered slightly. 3. Upcoming catalysts: OGA 32nd Offshore Licensing results expected by end of June 2020. Look at JOG SP reaction from last July. Selene drilling decision and Pensacola well investment decision could drop this year or early next year (both partnered with Shell). Dewar farm-out pending but likely to be delayed for the foreseeable given COVID. 4. ATOW valued at £10.2m, Allenby estimate £12m net cash by end of 2020. Fundraise completed last year, expected to see them through to end of 2021. 5. Broker targets: always take with a pinch of salt, but ultimately these get bandied about by rampers --Allenby re-confirmed in January 2020 a target of 8.3p and 16.7p (based on success for Selene, Pensacola and Dewar (assuming a 50% farm-out of Dewar). 6. "Read-across": ECO investors will know that the SP does react to success in neighbouring acreages (e.g. Guyana) and this could happen re Pensacola given the Darach Central-1 discovery in late 2019.
CLong
by AttilaTheKiller